We are live on
!
Find out more
SM
Sabby Management Portfolio holdings
AUM
$45.1M
1-Year Est. Return
74.25%
This Fund
S&P 500
This Quarter
Est. Return
+34.63%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$208M
AUM Growth
-$246M
(-54%)
Cap. Flow
-$176M
Cap. Flow
% of AUM
-84.46%
Top 10 Holdings %
Top 10 Hldgs %
83.47%
Holding
151
New
27
Increased
12
Reduced
37
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HMTV
Hemisphere Media Group, Inc.
HMTV
|
+$9.46M |
| 2 |
Loop Industries
LOOP
|
+$2.38M |
| 3 |
TRNX
Taronis Technologies, Inc. Common Stock
TRNX
|
+$1.52M |
| 4 |
Novavax
NVAX
|
+$1.36M |
| 5 |
CODX
Co-Diagnostics
CODX
|
+$928K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$37.5M |
| 2 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.39M |
| 3 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
+$4.97M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$4.47M |
| 5 |
Xeris Biopharma Holdings
XERS
|
+$3.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.57% |
| 2 | Materials | 0.95% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Technology | 0.61% |
| 5 | Industrials | 0.52% |
Similar funds
CG
OC
ICCON
PCM
CAS
CM
MCMC
CTC
Sabby Management's Q1 2019 Portfolio in Review
As of Q1 2019, Sabby Management held 151 positions worth $208M, down 54% from $455M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Sabby Management withdrew a net $176M in Q1 2019, closing 67 positions and reducing 37 holdings. Its most notable exit was Esperion Therapeutics, an estimated $6.39M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 21% a quarter earlier, followed by Materials and Consumer Discretionary.
Against the trend, Sabby Management opened a new position in Hemisphere Media Group, Inc. worth $113K.
- Sabby Management's largest Q1 2019 buy was Hemisphere Media Group, Inc.: 708,417 shares worth $113K.
- Sabby Management added most to OpGen, Inc in Q1 2019, an estimated $921K increase.
- Sabby Management's biggest Q1 2019 reduction was Biogen, cutting an estimated $37.5M.
- Sabby Management fully exited Esperion Therapeutics in Q1 2019, selling an estimated $6.39M.
- Sabby Management's ten largest holdings make up 83% of its $208M portfolio in Q1 2019.
- Sabby Management opened 27 new positions and closed 67 in Q1 2019.
- Sabby Management's portfolio value fell 54% quarter-over-quarter to $208M.
Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.